Proactiveinvestors Australia Zelira Therapeutics Ltd https://www.proactiveinvestors.com.au Proactiveinvestors Australia Zelira Therapeutics Ltd RSS feed en Thu, 28 Jan 2021 06:30:43 +1100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Zelira Therapeutics forms exclusive licensing deal to distribute its HOPE products in Washington DC https://www.proactiveinvestors.com.au/companies/news/936874/zelira-therapeutics-forms-exclusive-licensing-deal-to-distribute-its-hope-products-in-washington-dc-936874.html Thu, 17 Dec 2020 15:55:00 +1100 https://www.proactiveinvestors.com.au/companies/news/936874/zelira-therapeutics-forms-exclusive-licensing-deal-to-distribute-its-hope-products-in-washington-dc-936874.html Zelira Therapeutics in exclusive licensing deal with Alternative Solutions for distribution of HOPE™ products in Washington DC https://www.proactiveinvestors.com.au/companies/news/936358/zelira-therapeutics-in-exclusive-licensing-deal-with-alternative-solutions-for-distribution-of-hope-products-in-washington-dc-936358.html Sun, 13 Dec 2020 22:25:00 +1100 https://www.proactiveinvestors.com.au/companies/news/936358/zelira-therapeutics-in-exclusive-licensing-deal-with-alternative-solutions-for-distribution-of-hope-products-in-washington-dc-936358.html Zelira Therapeutics cash balance boosted by $1.378 million R&D tax refund https://www.proactiveinvestors.com.au/companies/news/936269/zelira-therapeutics-cash-balance-boosted-by-1378-million-rd-tax-refund-936269.html Thu, 10 Dec 2020 22:42:00 +1100 https://www.proactiveinvestors.com.au/companies/news/936269/zelira-therapeutics-cash-balance-boosted-by-1378-million-rd-tax-refund-936269.html Zelira Therapeutics partners with SprinJene to launch first over-the-counter CBD toothpaste in the US https://www.proactiveinvestors.com.au/companies/news/935428/zelira-therapeutics-partners-with-sprinjene-to-launch-first-over-the-counter-cbd-toothpaste-in-the-us-935428.html Tue, 01 Dec 2020 21:58:00 +1100 https://www.proactiveinvestors.com.au/companies/news/935428/zelira-therapeutics-partners-with-sprinjene-to-launch-first-over-the-counter-cbd-toothpaste-in-the-us-935428.html Zelira Therapeutics and Emyria team up for 'disruptive' autism spectrum disorder trial https://www.proactiveinvestors.com.au/companies/news/933525/zelira-therapeutics-and-emyria-team-up-for--disruptive--autism-spectrum-disorder-trial-933525.html Tue, 10 Nov 2020 02:04:00 +1100 https://www.proactiveinvestors.com.au/companies/news/933525/zelira-therapeutics-and-emyria-team-up-for--disruptive--autism-spectrum-disorder-trial-933525.html Zelira Therapeutics partners with Emyria for autism observational trial for HOPE products https://www.proactiveinvestors.com.au/companies/news/933381/zelira-therapeutics-partners-with-emyria-for-autism-observational-trial-for-hope-products-933381.html Sun, 08 Nov 2020 21:54:00 +1100 https://www.proactiveinvestors.com.au/companies/news/933381/zelira-therapeutics-partners-with-emyria-for-autism-observational-trial-for-hope-products-933381.html Zelira Therapeutics launches HOPE™ autism products in Australia through TGA Special Access Scheme https://www.proactiveinvestors.com.au/companies/news/932416/zelira-therapeutics-launches-hope-autism-products-in-australia-through-tga-special-access-scheme-932416.html Mon, 26 Oct 2020 21:44:00 +1100 https://www.proactiveinvestors.com.au/companies/news/932416/zelira-therapeutics-launches-hope-autism-products-in-australia-through-tga-special-access-scheme-932416.html Zelira Therapeutics secures $2 million strategic investment and new substantial shareholder https://www.proactiveinvestors.com.au/companies/news/929729/zelira-therapeutics-secures-2-million-strategic-investment-and-new-substantial-shareholder-929729.html Tue, 22 Sep 2020 23:16:00 +1000 https://www.proactiveinvestors.com.au/companies/news/929729/zelira-therapeutics-secures-2-million-strategic-investment-and-new-substantial-shareholder-929729.html Zelira Therapeutics launches Zenivol™ product in Australia after TGA adds to Special Access Scheme https://www.proactiveinvestors.com.au/companies/news/929162/zelira-therapeutics-launches-zenivol-product-in-australia-after-tga-adds-to-special-access-scheme-929162.html Wed, 16 Sep 2020 02:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/929162/zelira-therapeutics-launches-zenivol-product-in-australia-after-tga-adds-to-special-access-scheme-929162.html Zelira Therapeutics with Proactive at ASX Small and Mid-Cap Conference https://www.proactiveinvestors.com.au/companies/news/928721/zelira-therapeutics-with-proactive-at-asx-small-and-mid-cap-conference-928721.html Thu, 10 Sep 2020 05:47:00 +1000 https://www.proactiveinvestors.com.au/companies/news/928721/zelira-therapeutics-with-proactive-at-asx-small-and-mid-cap-conference-928721.html Zelira Therapeutics forms subsidiary to launch hemp-derived oral care products in the USA https://www.proactiveinvestors.com.au/companies/news/928444/zelira-therapeutics-forms-subsidiary-to-launch-hemp-derived-oral-care-products-in-the-usa-928444.html Mon, 07 Sep 2020 23:33:00 +1000 https://www.proactiveinvestors.com.au/companies/news/928444/zelira-therapeutics-forms-subsidiary-to-launch-hemp-derived-oral-care-products-in-the-usa-928444.html Zelira Therapeutics expands US network with Louisiana launch of HOPE products for autism sufferers https://www.proactiveinvestors.com.au/companies/news/927086/zelira-therapeutics-expands-us-network-with-louisiana-launch-of-hope-products-for-autism-sufferers-927086.html Wed, 19 Aug 2020 23:25:00 +1000 https://www.proactiveinvestors.com.au/companies/news/927086/zelira-therapeutics-expands-us-network-with-louisiana-launch-of-hope-products-for-autism-sufferers-927086.html Zelira Therapeutics MD shows faith in medical cannabis strategy with placement participation https://www.proactiveinvestors.com.au/companies/news/926752/zelira-therapeutics-md-shows-faith-in-medical-cannabis-strategy-with-placement-participation-926752.html Sun, 16 Aug 2020 23:28:00 +1000 https://www.proactiveinvestors.com.au/companies/news/926752/zelira-therapeutics-md-shows-faith-in-medical-cannabis-strategy-with-placement-participation-926752.html Zelira Therapeutics set to roll-out products in more US states using licensing model https://www.proactiveinvestors.com.au/companies/news/926326/zelira-therapeutics-set-to-roll-out-products-in-more-us-states-using-licensing-model-926326.html Tue, 11 Aug 2020 06:49:00 +1000 https://www.proactiveinvestors.com.au/companies/news/926326/zelira-therapeutics-set-to-roll-out-products-in-more-us-states-using-licensing-model-926326.html Zelira Therapeutics to outline progress of Zenivol™ and HOPE™ at Proactive's medical cannabis webinar on Aug 11 https://www.proactiveinvestors.com.au/companies/news/926091/zelira-therapeutics-to-outline-progress-of-zenivol-and-hope-at-proactive-s-medical-cannabis-webinar-on-aug-11-926091.html Fri, 07 Aug 2020 04:57:00 +1000 https://www.proactiveinvestors.com.au/companies/news/926091/zelira-therapeutics-to-outline-progress-of-zenivol-and-hope-at-proactive-s-medical-cannabis-webinar-on-aug-11-926091.html Three medical cannabis companies in focus at Proactive’s webinar on August 11 https://www.proactiveinvestors.com.au/companies/news/925993/three-medical-cannabis-companies-in-focus-at-proactives-webinar-on-august-11-925993.html Thu, 06 Aug 2020 08:05:00 +1000 https://www.proactiveinvestors.com.au/companies/news/925993/three-medical-cannabis-companies-in-focus-at-proactives-webinar-on-august-11-925993.html Zelira Therapeutics accelerates transition to revenue-generation with Zenivol™ and HOPE™ launch in Australia by quarter-end https://www.proactiveinvestors.com.au/companies/news/925907/zelira-therapeutics-accelerates-transition-to-revenue-generation-with-zenivol-and-hope-launch-in-australia-by-quarter-end-925907.html Thu, 06 Aug 2020 02:05:00 +1000 https://www.proactiveinvestors.com.au/companies/news/925907/zelira-therapeutics-accelerates-transition-to-revenue-generation-with-zenivol-and-hope-launch-in-australia-by-quarter-end-925907.html Zelira Therapeutics raises A$8.75 million to accelerate launch of products into global markets https://www.proactiveinvestors.com.au/companies/news/925640/zelira-therapeutics-raises-a875-million-to-accelerate-launch-of-products-into-global-markets-925640.html Mon, 03 Aug 2020 03:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/925640/zelira-therapeutics-raises-a875-million-to-accelerate-launch-of-products-into-global-markets-925640.html Zelira Therapeutics in trading halt ahead of capital raising news https://www.proactiveinvestors.com.au/companies/news/925412/zelira-therapeutics-in-trading-halt-ahead-of-capital-raising-news-925412.html Thu, 30 Jul 2020 04:09:00 +1000 https://www.proactiveinvestors.com.au/companies/news/925412/zelira-therapeutics-in-trading-halt-ahead-of-capital-raising-news-925412.html Zelira Therapeutics enters commercial agreement to develop products for vascular diseases https://www.proactiveinvestors.com.au/companies/news/924776/zelira-therapeutics-enters-commercial-agreement-to-develop-products-for-vascular-diseases-924776.html Wed, 22 Jul 2020 04:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/924776/zelira-therapeutics-enters-commercial-agreement-to-develop-products-for-vascular-diseases-924776.html Zelira Therapeutics halted ahead of a licensing agreement in the United States https://www.proactiveinvestors.com.au/companies/news/924542/zelira-therapeutics-halted-ahead-of-a-licensing-agreement-in-the-united-states-924542.html Mon, 20 Jul 2020 05:23:00 +1000 https://www.proactiveinvestors.com.au/companies/news/924542/zelira-therapeutics-halted-ahead-of-a-licensing-agreement-in-the-united-states-924542.html Zelira Therapeutics dose escalation trial for chronic pain meets safety and efficacy endpoints https://www.proactiveinvestors.com.au/companies/news/924073/zelira-therapeutics-dose-escalation-trial-for-chronic-pain-meets-safety-and-efficacy-endpoints-924073.html Mon, 13 Jul 2020 23:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/924073/zelira-therapeutics-dose-escalation-trial-for-chronic-pain-meets-safety-and-efficacy-endpoints-924073.html Zelira Therapeutics forming new partnership for chronic pain study in retired athletes https://www.proactiveinvestors.com.au/companies/news/922076/zelira-therapeutics-forming-new-partnership-for-chronic-pain-study-in-retired-athletes-922076.html Wed, 17 Jun 2020 02:07:00 +1000 https://www.proactiveinvestors.com.au/companies/news/922076/zelira-therapeutics-forming-new-partnership-for-chronic-pain-study-in-retired-athletes-922076.html Zelira Therapeutics finalises appointment terms of US CEO and managing director https://www.proactiveinvestors.com.au/companies/news/921082/zelira-therapeutics-finalises-appointment-terms-of-us-ceo-and-managing-director-921082.html Wed, 03 Jun 2020 23:08:00 +1000 https://www.proactiveinvestors.com.au/companies/news/921082/zelira-therapeutics-finalises-appointment-terms-of-us-ceo-and-managing-director-921082.html Zelira Therapeutics signs commercial agreement for supply of Insomnia and HOPE products https://www.proactiveinvestors.com.au/companies/news/920336/zelira-therapeutics-signs-commercial-agreement-for-supply-of-insomnia-and-hope-products-920336.html Tue, 26 May 2020 03:56:00 +1000 https://www.proactiveinvestors.com.au/companies/news/920336/zelira-therapeutics-signs-commercial-agreement-for-supply-of-insomnia-and-hope-products-920336.html Zelira Therapeutics in discussions to license medicinal cannabis products in US https://www.proactiveinvestors.com.au/companies/news/918457/zelira-therapeutics-in-discussions-to-license-medicinal-cannabis-products-in-us-918457.html Thu, 30 Apr 2020 04:45:00 +1000 https://www.proactiveinvestors.com.au/companies/news/918457/zelira-therapeutics-in-discussions-to-license-medicinal-cannabis-products-in-us-918457.html Zelira Therapeutics shares surge after clinically validating medicinal cannabis for insomnia https://www.proactiveinvestors.com.au/companies/news/916755/zelira-therapeutics-shares-surge-after-clinically-validating-medicinal-cannabis-for-insomnia-916755.html Tue, 07 Apr 2020 02:46:00 +1000 https://www.proactiveinvestors.com.au/companies/news/916755/zelira-therapeutics-shares-surge-after-clinically-validating-medicinal-cannabis-for-insomnia-916755.html Zelira Therapeutics accelerates towards commercialisation in 2020 https://www.proactiveinvestors.com.au/companies/news/915275/zelira-therapeutics-accelerates-towards-commercialisation-in-2020-915275.html Thu, 19 Mar 2020 06:01:00 +1100 https://www.proactiveinvestors.com.au/companies/news/915275/zelira-therapeutics-accelerates-towards-commercialisation-in-2020-915275.html Emerald Clinics gets nod for Zelira's opioid sparing clinical trial https://www.proactiveinvestors.com.au/companies/news/913792/emerald-clinics-gets-nod-for-zelira-s-opioid-sparing-clinical-trial-913792.html Thu, 27 Feb 2020 03:35:00 +1100 https://www.proactiveinvestors.com.au/companies/news/913792/emerald-clinics-gets-nod-for-zelira-s-opioid-sparing-clinical-trial-913792.html Zelira Therapeutics fully enrols cannabis clinical trial https://www.proactiveinvestors.com.au/companies/news/913775/zelira-therapeutics-fully-enrols-cannabis-clinical-trial-913775.html Wed, 26 Feb 2020 22:31:00 +1100 https://www.proactiveinvestors.com.au/companies/news/913775/zelira-therapeutics-fully-enrols-cannabis-clinical-trial-913775.html